✦ LIBER ✦

1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN FOR 28 DAYS IN TREATMENT NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1

✍ Scribed by Jacobson, I.; Pockros, P.; Lalezari, J.; Lawitz, E.; Rodriguez-Torres, M.; DeJesus, E.; Haas, F.; Martorell, C.; Pruitt, R.; Durham, K.; Srinivasan, S.; Rosario, M.; Jagannatha, S.; Hammond, J.

Book ID: 123319493
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 70 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(09)61054-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2005 VIROLOGIC RESPONSE RATES FOLLOWING

2005 VIROLOGIC RESPONSE RATES FOLLOWING 4 WEEKS OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONICALLY-INFECTED HCV GENOTYPE-1 PATIENTS

✍ Jacobson, I.; Pockros, P.J.; Lalezari, J.; Lawitz, E.; Rodriguez-Torres, M.; DeJ 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

2009 SAFETY AND ANTIVIRAL ACTIVITY OF AN

2009 SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON α2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS

✍ Lawitz, E.; Rodriquez-Torres, M.; Rustgi, V.K.; Hassanein, T.; Rahimy, M.H.; Cro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

2013 ANTIVIRAL ACTIVITY, PHARMACOKINETIC

2013 ANTIVIRAL ACTIVITY, PHARMACOKINETICS AND SAFETY OF IDX184 IN COMBINATION WITH PEGYLATED INTERFERON (PEGIFN) AND RIBAVIRIN (RBV) IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED SUBJECTS

✍ Lalezari, J.; Poordad, F.; Mehra, P.; Nguyen, T.; Dejesus, E.; Godofsky, E.; Pat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

1008 PEG-interferon alfa-2B and ribaviri

1008 PEG-interferon alfa-2B and ribavirin in treatment naive African American patients infected with HCV genotype 1

✍ STEIN, D; MCKENZIE, S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

[50] ANTIVIRAL ACTIVITY OF THE NON-NUCLE

[50] ANTIVIRAL ACTIVITY OF THE NON-NUCLEOSIDE POLYMERASE INHIBITOR, HCV-796, IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2b IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV

✍ S.A. Villano; D. Raible; D. Harper; J. Speth; P. Chandra; P. Shaw; G. Bichier 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Faldaprevir combined with pegylated inte

Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial

✍ Sulkowski, Mark S.; Asselah, Tarik; Lalezari, Jacob; Ferenci, Peter; Fainboim, H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB